title: Thromboembolism associated with the new contraceptive Yasmin.
authors.affiliation: Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH 's-Hertogenbosch, Netherlands. ac.vangrootheest@lareb.nl
authors.forename: Kees
authors.initials: K
authors.lastname: van Grootheest
authors.forename: Tom
authors.initials: T
authors.lastname: Vrieling
mesh_terms: D000293:Adolescent; D000328:Adult; D000736:Androstenes / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D011655:Pulmonary Embolism / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000139:chemically induced
chemical_list: D000736:Androstenes; D003277:Contraceptives, Oral, Combined; D000451:Mineralocorticoid Receptor Antagonists; C035144:drospirenone